CD274 and cancer: The data in Table 5 show that patients who had PD-L1 levels between 58 and 79 pg/mL had a 3.8-fold risk of cancer relapse or metastases compared to patients with PD-L1 levels of less than 58 pg/mL (p = 0.003).